The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies. (Q38561977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Cassie L Odahowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

5 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

1357-1382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Programme costs in the economic evaluation of health interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The average cost of measles cases and adverse events following vaccination in industrialised countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The cost of measles in industrialised countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cost of measles containment in an ambulatory pediatric clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The costs of future polio risk management policies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The efficiency of measles and pertussis notification in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

FREQUENCY OF COMPLICATIONS OF MEASLES, 1963. REPORT ON A NATIONAL INQUIRY BY THE PUBLIC HEALTH LABORATORY SERVICE IN COLLABORATION WITH THE SOCIETY OF MEDICAL OFFICERS OF HEALTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The clinical significance of measles: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Measles elimination efforts and 2008-2011 outbreak, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Measles epidemiology in Catalonia (Spain): implications for a regional vaccination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Epidemiology of subacute sclerosing panencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Subacute sclerosing panencephalitis in England and Wales: Transient effects and risk estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Acute measles mortality in the United States, 1987-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Estimates of measles case fatality ratios: a comprehensive review of community-based studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Epidemiology of measles in Blantyre, Malawi: Analyses of passive surveillance data from 1996 to 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Benefit-cost analysis of rubella vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Neurologic disorders after measles-mumps-rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Pregnancy outcome following rubella vaccination: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Fetal risk associated with rubella vaccination during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Rubella Vaccination of Unknowingly Pregnant Women During Mass Campaigns for Rubella and Congenital Rubella Syndrome Elimination, The Americas 2001-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Antibiotics for preventing complications in children with measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Economic analysis of the global polio eradication initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone, Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Congenital heart disease in India: a status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cost-effectiveness of public-funded options for cataract surgery in Mysore, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Effectiveness of multi-channel unilateral cochlear implants for profoundly deaf children: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cochlear implantation in India: a public health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cochlear implantation in developing countries as humanitarian service: physician attitudes and recommendations for best practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Trends in educational placement and cost-benefit considerations in children with cochlear implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cost-utility analysis of the cochlear implant in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The economic cost of myopia in adults aged over 40 years in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Is There Enough Vaccine to Eradicate Measles? An Integrated Analysis of Measles-Containing Vaccine Supply and Demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Health Care-Associated Measles Outbreak in the United States After an Importation: Challenges and Economic Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Economic evaluation of the routine childhood immunization program in the United States, 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Cost-effectiveness of three different vaccination strategies against measles in Zambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Single versus multi-dose vaccine vials: an economic computational model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The economic burden of sixteen measles outbreaks on United States public health departments in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Research priorities for global measles and rubella control and eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Improving polio vaccination coverage in Nigeria through the use of geographic information system technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Characterization of Heterogeneity in Childhood Immunization Coverage in Central Florida Using Immunization Registry Data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

Geographic clusters in underimmunization and vaccine refusal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12459

21 January 2018

Identifiers

DOI

10.1111/RISA.12459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26249331%20AND%20SRC:MED&resulttype=core&format=json